Yoscelina Estrella Martínez-López

Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort

Daniel Neri-Rosario, Yoscelina Estrella Martínez-López, Diego Esquivel-Hernández et al. · Frontiers in Endocrinology · 2023 · 38 citations · Full text

The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial

Rodolfo Guardado‐Mendoza, Sara Stephania Salazar-López, Mildred Fátima de la Luz Alvarez-Canales et al. · Metabolism · 2019 · 32 citations

Metabolic Syndrome, Randomized Clinical Trial, Lifestyle Modification +6

On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers

Aarón Vázquez-Jiménez, Ugo Enrique Avila-Ponce De León, Meztli Matadamas-Guzmán et al. · Frontiers in Immunology · 2021 · 16 citations · Full text

Engineering, Severity Markers, Virus Epidemiology +24

A network perspective on the ecology of gut microbiota and progression of type 2 diabetes: Linkages to keystone taxa in a Mexican cohort

Diego Esquivel-Hernández, Yoscelina Estrella Martínez-López, Jean Paul Sánchez-Castañeda et al. · Frontiers in Endocrinology · 2023 · 16 citations · Full text

Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes

Yoscelina Estrella Martínez-López, Daniel Neri-Rosario, Diego Esquivel-Hernández et al. · Scientific Reports · 2024 · 16 citations · Full text